Viscient Biosciences is a biotechnology company working at the intersection of human 3D tissue technology and multi-omics analysis.
Viscient Biosciences has raised $1.0M in total funding. The most recent round was Debt Financing. The last funding was announced in September 2021.
Viscient Biosciences's investors include SternAegis, Harmonix Fund, Thynk Capital.
Viscient Biosciences is headquartered in San Diego, United States.
Viscient Biosciences is a biotechnology company working at the intersection of human 3D tissue technology and multi-omics analysis.
Viscient Biosciences is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Viscient Biosciences — Funding & Investors." VCBacked, September 15, 2021, https://www.vcbacked.co/company/viscient-biosciences. Accessed September 30, 2026.
VCBacked. (2021). Viscient Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/viscient-biosciences
{{cite web |title=Viscient Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/viscient-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated